FRAXEL RE:STORE LASER SYSTEM SYS-SR1500-D-US

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional report with the FDA on 2019-03-12 for FRAXEL RE:STORE LASER SYSTEM SYS-SR1500-D-US manufactured by Solta Medical, Inc..

Event Text Entries

[138562331] Product? S treatment tips do not deliver any energy and no treatment data is stored on the tip itself. There is no information to gather from their return; they are not a viable source of evaluation data. Additionally, the product has no system/data logs that can be reviewed. System has software safeguards (such as a power on self-test) that will trigger error/event codes should the system be outside of acceptable limits. The physician? S office reported neither any system errors nor anything out of the ordinary during treatment. Burn paper tests may also be used to confirm the system laser is providing correct pattern/coverage. Physician? S office performed burn paper test and sent it to the manufacturer for review. The burn paper tests have good differentiation in the dots between the four settings. The testing does not indicate any horizontal banding. Review of the burn paper showed proper pattern/coverage. Finally, according to the fraxel user manual (p009220-03 rev. A), burns and erythema are known possible complications of a fraxel treatment. Blistering or burns may develop over the treated areas. The possibility for scarring exists even with non-ablative fractional laser devices such fraxel. Local scarring may occur directly from laser exposure if treatment procedures are not followed properly, or from infection or physical irritation such as picking and rubbing. Mild-moderate transient erythema is an expected response. However, if erythema is severe or persists significantly longer than expected, re-treatment should be avoided until the condition resolves. Reactions may vary on a patient-to-patient basis. A review of the manufacturing records showed all requirements were met with no non-conformities or anomalies found when reviewing the product? S device history record. The lot history, trend analysis, risk analysis and/or directions for use review were considered acceptable, with the product performing within anticipated rates. Based on all the information, blisters and erythema are known possible complications of fraxel treatment.
Patient Sequence No: 1, Text Type: N, H10


[138562332] Physician? S office reported that patient was treated on (b)(6) 2019 and that two days post procedure the patient experienced blisters, erythema and excoriation over the forehead and temporal area. No other treatment was done on the area. The highest energy level used during the treatment was 20 mj with 8 passes. Office reported that the original treatment tip utilized had been used five times prior to the reported event but that they opened a new tip for the patient? S forehead and preauricular area. Available patient pictures were reviewed by the manufacturer and blisters, erythema and scabs are visible over the patient's face and forehead. Follow-up information obtained from the office indicates that the patient received clobetasol 0. 5% ointment for three days and v-beam to moderate the erythema. Physician? S office notes that the patient is healing and has improved greatly. As of (b)(6) 2019, office is still treating patient for erythema with v-beam. Whether a permanent scar will remain is yet to be determined.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3011423170-2019-00033
MDR Report Key8413306
Report SourceHEALTH PROFESSIONAL
Date Received2019-03-12
Date of Report2019-02-11
Date of Event2019-02-06
Device Manufacturer Date2011-12-28
Date Added to Maude2019-03-12
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. JENNIFER GAMET
Manufacturer Street1400 NORTH GOODMAN STREET
Manufacturer CityROCHESTER NY 14609
Manufacturer CountryUS
Manufacturer Postal14609
Manufacturer Phone5853386853
Manufacturer G1SOLTA MEDICAL, INC.
Manufacturer Street11720 N CREEK PARKWAY N STE 100
Manufacturer CityBOTHELL WA 98011
Manufacturer CountryUS
Manufacturer Postal Code98011
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameFRAXEL RE:STORE LASER SYSTEM
Generic NamePOWERED LASER SURGICAL INSTRUMENT WITH MICROBEAM
Product CodeONG
Date Received2019-03-12
Model NumberSYS-SR1500-D-US
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerSOLTA MEDICAL, INC.
Manufacturer Address11720 NORTH CREEK PKWY N SUITE 100 BOTHEL WA 98011 US 98011


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2019-03-12

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.